Hypothetical review: Thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes

Clinical and Experimental Immunology

Volumn 154, Issue 1, 2008, Pages 141-151

  Meager, A ^b   Peterson, P ^c   Willcox, N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

AIRE; APECED; Autoantibody; Autoimmunity; Autoimmunization; Myasthenia gravis; Self tolerance; Thymic epithelial cells; Thymoma; Thymus; Type I interferon

Indexed keywords

ALPHA INTERFERON; AUTOIMMUNE REGULATOR PROTEIN; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON ANTIBODY; INTERFERON LAMBDA; NEUTRALIZING ANTIBODY; OMEGA INTERFERON; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE MUTATION; GENOTYPE; HUMAN; INNATE IMMUNITY; IPEX SYNDROME; MYASTHENIA GRAVIS; NONHUMAN; PARANEOPLASTIC SYNDROME; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMECTOMY; THYMOMA;

AUTOANTIBODIES; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERFERON TYPE I; MODELS, IMMUNOLOGICAL; PARANEOPLASTIC SYNDROMES; POLYENDOCRINOPATHIES, AUTOIMMUNE; SELF TOLERANCE; THYMOMA; THYMUS GLAND;

EID: 51349151253     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03739.x     Document Type: Review

References (103)

1. Ochs H D, Ziegler S F, Torgerson TR. Foxp3 acts as a rheostat of the immune response. Immunol Revs 2005 203 : 156 64.
2. Wildin RS, Freitas A. IPEX and FOXP3: clinical and research perspectives. J Autoimmun 2005 25 (Suppl 56 62.
3. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007 445 : 766 70.
4. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007 8 : 457 62.
5. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006 91 : 2843 50.
6. Peterson P, Uibo AR, Kampe O. Polyendocrine syndromes. In : Rose N, Mackay IR, eds. The autoimmune diseases, 4th edn. Amsterdam : Elsevier, Academic press, 2007 : 515 26.
7. Söderbergh A, Myhre AG, Ekwall O et al. Prevalence and clinical association of 10 defined autoantibodies in autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2004 89 : 557 62.
8. Brännström J, Hässler S, Peltonen L, Herrmann B, Winqvist O. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens. Clin Immunol 2006 121 : 265 73.
9. Kyewski B, Klein L. A central role for central tolerance. Annu. Revs. Immunol 2006 24 : 571 606.
10. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002 298 : 1395 401.
11. Liston A, Gray DH, Lesage S et al. Gene dosage - limiting role of Aire in thymic expression, clonal deletion, and organ-specific auto-immunity. J Exp Med 2004 200 : 1015 26.
12. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self-tolerance and autoimmunity. Nature 2005 435 : 590 7.
13. Mathis D, Benoist C. A decade of AIRE. Nat Revs Immunol 2007 7 : 645 50.
14. DeVoss J, Hou Y, Johannes K et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 2006 203 : 2727 35.
15. Niki S, Oshikawa K, Mouri Y et al. Alteration of intra-pancreatic target-organ specificity by abrogating Aire in NOD mice. J Clin Invest 2006 116 : 1292 301.
16. Chin RK, Zhu M, Christiansen PA et al. Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen. J Immunol 2006 177 : 290 7.
17. Rossi SW, Kim MY, Leibbrandt A et al. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med 2007 204 : 1267 72.
18. Kuroda N, Mitani T, Takeda N et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 2005 174 : 1862 70.
19. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005 23 : 227 39.
20. Ramsey C, Hassler S, Marits P et al. Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator. Eur J Immunol 2006 36 : 305 17.
21. Ryan KR, Lawson CA, Lorenzi AR, Arkwright PD, Isaacs JD, Lilic D. CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J All Clin Immunol 2005 116 : 1158 9.
22. Kekalainen E, Tuovinen H, Joensuu J et al. A defect of regulatory T cells in patients with auto-immune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 2007 178 : 1208 15.
23. Aschenbrenner K, D'Cruz LM, Vollmann EH et al. Selection of Foxp3(+) regulatory T cells specific for self antigen expressed and presented by Aire(+) medullary thymic epithelial cells. Nat Immunol 2007 8 : 351 8.
24. Pöntynen N, Miettinen A, Arstila TP et al. Aire- deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun 2006 27 : 96 104.
25. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997 15 : 289 92.
26. Pugliese A, Zeller M, Fernandez A et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997 15 : 293 7.
27. Giraud M, Taubert R, Vandiedonck C et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 2007 448 : 934 7.
28. Yamanouchi J, Rainbow D, Serra P et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007 39 : 329 37.
29. Pestka S., Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Revs 2004 202 : 8 32.
30. Sheppard P, Kindsvogel W, Xu W et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003 4 : 63 8.
31. Kotenko S, Gallagher G, Baurin VV et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003 4 : 69 77.
32. Berenson LS, Ota N, Murphy KM. Issues in t-helper 1 development - resolved and unresolved. Immunol Rev 2004 202 : 157 74.
33. Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999 5 : 919 23.
34. Nakhaei P, Paz S, Hiscott J. Activation of interferon gene expression through Toll-like receptor-dependent and -independent pathways. In : Meager A, ed. The interferons: characterization and application. Weinheim : Wiley VCH, 2004 : 35 61.
35. Ronnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006 54 : 408 20.
36. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006 25 : 383 92.
37. Gota C, Calabrese L. Induction of clinical autoimmune disease by therapeutic interferon alpha. Autoimmunity 2003 36 : 511 18.
38. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol 2007 19 : 61 6.
39. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007 8 : 492 502.
40. Zhuang H, Kosboth M, Lee P et al. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. Arthritis Rheum 2006 54 : 1573 9.
41. Sigurdsson S, Göring HH, Kristjansdottir G et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 reveals a novel 5bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 2008 17 : 872 81.
42. Graham RR, Kozyrev SV, Baechler EC et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006 38 : 550 5.
43. Bauer JW, Baechler EC, Petri M et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 2006 3 : e491.
44. Panem S, Check IJ, Henriksen D, Vilcek J. Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. J Immunol 1982 129 : 1 3.
45. Slavikova M, Schmeisser H, Kontsekova E, Mateicka F, Borecky L, Kontsek P. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. J Interferon Cytokine Res 2003 23 : 143 7.
46. Meager A, Wadhwa M, Dilger P et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 2003 132 : 128 36.
47. Antonelli G. In vivo development of antibody to interferons: an up-date to 1996. J Interferon Cytokine Res 1997 17 (Suppl. 1 S39 46.
48. Wadhwa M, Meager A, Dilger P et al. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1α and interferon-α but not other cytokines in human immunoglobulin preparations. Immunology 2000 99 : 113 23.
49. Willcox N., Sheppard M, Loehrer PJ. Thymic tumours and their autoimmune associations. In : Souhami RL, Tannock I, Hohenberger, P, Horiot J-C, eds. Oxford textbook of oncology, 2nd edn. Oxford : Oxford University Press, 2002 : 2143 52.
50. Kadota Y, Okumura M, Miyoshi S et al. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma). Clin Exp Immunol 2000 121 : 59 68.
51. Ströbel P, Murumagi A, Klein R et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 2007 211 : 563 71.
52. Scarpino S, Di Napoli A, Stoppacciaro A et al. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol 2007 149 : 504 12.
53. Meager A, Visvalingam K, Peterson P et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type-1. PloS Med 2006 3 : e289.
54. Shiono H, Roxanis I, Zhang W et al. Scenarios for auto-immunization of T and B cells in myasthenia gravis. Ann NY Acad Sci 2003 998 : 237 56.
55. Conley ME. Immunodeficiency: UNC-93B gets a toll call. Trends Immunol 2007 28 : 99 100.
56. Patel SY, Ding L, Brown MR et al. Anti-IFN-gamma autoantibodies in disseminated non-tuberculous mycobacterial infections. J Immunol 2005 175 : 4769 76.
57. Wolff AS, Erichsen MM, Meager A et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007 92 : 595 603.
58. Cetani F, Barbesino G, Borsari S et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly co-segregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001 86 : 4747 52.
59. Buzi F, Badolato R, Mazza C et al. Autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J Clin Endocrinol Metab 2003 88 : 3146 8.
60. Barker JM, Barriga KJ, Yu L et al. Prediction of autoantibody positivity and progression to type I diabetes. Diabetes autoimmunity study in the young (DAISY). J. Clin Endocrinol Metab 2004 89 : 3896 902.
61. Guo B, Chang EY, Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 2008 118 : 1680 90.
62. Milner JD, Brenchley JM, Laurence A et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008 452 : 773 6.
63. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008 180 : 5157 62.
64. Nagafuchi S, Umene K, Yamanaka F et al. Recurrent herpes simplex virus infection in a patient with auto-immune polyendocrinopathy-candidiasis- ectodermal dystrophy associated with L29P and IVS9-1G>C compound heterozygous autoimmune regulator gene mutations. J Intern Med 2007 261 : 605 10.
65. Kisand K, Link M, Wolff AS et al. Interferon autoantibodies associated with AIRE-deficiency decrease the expression of IFN-stimulated genes. Blood 2008 (in press).
66. Flohr F, Schneider-Schaulies S, Haller O, Kochs G. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett 1999 463 : 24 8.
67. Khan NU, Gibson A, Foulis AK. The distribution of immunoreactive interferon-alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues. Immunology 1990 71 : 230 5.
68. Schmidlin H, Dontje W, Groot F et al. Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood 2006 108 : 3792 800.
69. Willcox N, Leite MI, Kadota Y et al. Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci 2008 1132 : 163 173.
70. Nestlé FO, Conrad C, Tun-Kyi A et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-{alpha} production. J Exp Med 2005 202 : 135 43.
71. Chan CW, Crafton E, Fan HN et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006 12 : 207 13.
72. Lee JW, Epardaud M, Sun J et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 2007 8 : 181 90.
73. Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004 199 : 173 83.
74. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 2003 198 : 1527 37.
75. Maldonado MA, Kakkanaiah V, MacDonald GC et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 1999 162 : 6322 30.
76. Trouw LA, Daha MR. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis. Expert Opin Biol Ther 2005 5 : 243 51.
77. Wermeling F, Chen Y, Pikkarainen T et al. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J Exp Med 2007 204 : 2259 65.
78. Obeid M, Tesniere A, Ghiringhelli F et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007 13 : 54 61.
79. Ferrantini M, Capone I, Belardelli F. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 2007 89 : 884 93.
80. Hanayama R, Tanaka M, Miyasaka K et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004 304 : 1147 50.
81. Baumann I, Kolowos W, Voll RE et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002 46 : 191 201.
82. Barrat FJ, Meeker T, Gregorio J et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005 202 : 1131 9.
83. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006 312 : 1669 72.
84. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007 13 : 543 51.
85. Martin DA, Elkon KB. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I IFNs predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum 2006 54 : 951 62.
86. Wagner H, Bauer S. All is not Toll: new pathways in DNA recognition. J Exp Med 2006 203 : 265 8.
87. Nagata S. DNA degradation in development and programmed cell death. Annu Revs Immunol 2005 23 : 853 75.
88. Crow YJ, Leitch A, Hayward BE et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet 2006 38 : 910 6.
89. Diebold SS, Massacrier C, Akira S, Paturel C, Morel Y, Reis e Sousa C. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 2006 36 : 3256 67.
90. Gallucci S, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999 5 : 1249 55.
91. Apetoh L, Ghiringhelli F, Tesniere A et al. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 2007 220 : 47 59.
92. Sato K, Sato U, Tateishi S et al. Aire downregulates multiple molecules that have contradicting immune-enhancing and immune-suppressive functions. Biochem Biophys Res Commun 2004 318 : 935 40.
93. Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med 2007 204 : 2521 8.
94. Ferguson BJ, Alexander CE, Rossi SW et al. AIRE's card revealed; a new structure for central tolerance provokes transcriptional plasticity. J Biol Chem 2008 283 : 1723 31.
95. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 2005 6 : 49 56.
96. Kawane K, Fukuyama H, Yoshida H et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat Immunol 2003 4 : 138 44.
97. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007 130 : 25 35.
98. Haeryfar SM. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? Trends Immunol 2005 26 : 311 7.
99. Matsumoto M, Funami K, Tanabe M et al. Subcellular localization of Toll-like R 3 in human DC. J Immunol 2003 171 : 3154 62.
100. Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 2002 128 : 82 9.
101. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999 190 : 815 26.
102. Vermi W., Facchetti F, Rosati S et al. Nodal and extra-nodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 2004 28 : 585 95.
103. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005 52 : 201 11.